BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 32453443)

  • 21. Multiple Cavitary Lung Metastases from Prostate Adenocarcinoma.
    Nakatani Y; Ohnishi H; Terada J; Yokoyama A
    Am J Respir Crit Care Med; 2023 Apr; 207(8):1092-1094. PubMed ID: 36315854
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary neuroendocrine prostate cancer with adrenal gland metastasis.
    Muñoz López AY; Domínguez Castillo RE; Rodenas Gil EA; Navarro Ruesga I; Morales Montor JG; Pacheco Gahbler C
    Urol Case Rep; 2022 Jan; 40():101896. PubMed ID: 34745894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Impact of prostate cancer on the nervous system: two different cases and a review of the literature.].
    Cedeira F; Montes de Oca LF; Martínez Pagano E
    Arch Esp Urol; 2021 Sep; 74(7):715-719. PubMed ID: 34472442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival in Patients With De Novo Metastatic Prostate Cancer.
    Schoen MW; Montgomery RB; Owens L; Khan S; Sanfilippo KM; Etzioni RB
    JAMA Netw Open; 2024 Mar; 7(3):e241970. PubMed ID: 38470422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies.
    Ranasinghe W; Shapiro DD; Hwang H; Wang X; Reichard CA; Elsheshtawi M; Achim MF; Bathala T; Tang C; Aparicio A; Tu SM; Navone N; Thompson TC; Pisters L; Troncoso P; Davis JW; Chapin BF
    Eur Urol; 2021 Feb; 79(2):298-306. PubMed ID: 33279304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Survival Outcomes and Risk Factors Between Ductal Carcinoma of the Prostate and Acinar Adenocarcinoma of the Prostate: A Population-based Propensity Score-matching Study.
    Wei Y; Kobayashi T; Lu Y; Vogel M; Zhang R; Wu J; Gao Y; Lin L; Zhu Q; Ye L; Horie S; Wang X; Li T
    Eur Urol Open Sci; 2022 Dec; 46():88-95. PubMed ID: 36506256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The great escape: A tale of the visiting professor's Artful Dodge.
    Davis JW
    BJUI Compass; 2021 Jan; 2(1):3-6. PubMed ID: 35474663
    [No Abstract]   [Full Text] [Related]  

  • 28. Vasohibin-1 expression as a biomarker of aggressive nature in ductal adenocarcinoma of the prostate: a retrospective cohort study at two centres in Japan.
    Kobayashi H; Kosaka T; Mikami S; Kimura T; Hongo H; Kosugi M; Sato Y; Oya M
    BMJ Open; 2021 Nov; 11(11):e056439. PubMed ID: 34819292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long Non-Coding RNA (lncRNA) RAMS11 Promotes Metastatis and Cell Growth of Prostate Cancer by CBX4 Complex Binding to Top2α.
    Zheng Z; Qiu K; Huang W
    Cancer Manag Res; 2021; 13():913-923. PubMed ID: 33564266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
    Zagars GK; Pollack A; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing the diagnosis and management of ductal prostate cancer.
    Ranasinghe W; Shapiro DD; Zhang M; Bathala T; Navone N; Thompson TC; Broom B; Aparicio A; Tu SM; Tang C; Davis JW; Pisters L; Chapin BF
    Nat Rev Urol; 2021 Jun; 18(6):337-358. PubMed ID: 33824525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy.
    Robertson NL; Sala E; Benz M; Landa J; Scardino P; Scher HI; Hricak H; Vargas HA
    J Urol; 2017 Jul; 198(1):65-70. PubMed ID: 28216327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of metastases of prostatic ductal adenocarcinoma.
    Ranasinghe WKB; Brooks NA; Elsheshtawi MA; Davis JW; Bathala TK; Tang C; Troncoso P; Aparicio A; Tu SM; Pisters LL; Chapin BF
    Cancer; 2020 Aug; 126(16):3667-3673. PubMed ID: 32453443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study.
    Seipel AH; Samaratunga H; Delahunt B; Wiklund P; Clements M; Egevad L
    APMIS; 2016 Apr; 124(4):263-70. PubMed ID: 26778368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features.
    Seipel AH; Delahunt B; Samaratunga H; Egevad L
    Pathology; 2016 Aug; 48(5):398-405. PubMed ID: 27321992
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.